Brokerages Set Endava PLC Sponsored ADR (NYSE:DAVA) Price Target at $25.22

Endava PLC Sponsored ADR (NYSE:DAVAGet Free Report) has earned an average rating of “Hold” from the ten brokerages that are covering the company, MarketBeat reports. Seven analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is $25.22.

Several research analysts have weighed in on the stock. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $18.00 target price on shares of Endava in a research note on Monday, May 19th. Wall Street Zen raised shares of Endava from a “hold” rating to a “buy” rating in a research note on Saturday, June 14th. Deutsche Bank Aktiengesellschaft began coverage on shares of Endava in a research note on Thursday, July 17th. They set a “hold” rating and a $14.00 target price for the company. TD Cowen lowered shares of Endava from a “buy” rating to a “hold” rating and set a $17.00 price objective for the company. in a research note on Thursday, May 15th. Finally, Susquehanna reduced their target price on shares of Endava from $50.00 to $42.00 and set a “positive” rating on the stock in a report on Tuesday, May 20th.

Get Our Latest Stock Report on Endava

Institutional Trading of Endava

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Kayne Anderson Rudnick Investment Management LLC grew its position in Endava by 36.7% in the 1st quarter. Kayne Anderson Rudnick Investment Management LLC now owns 6,198,846 shares of the company’s stock valued at $120,939,000 after buying an additional 1,665,735 shares during the last quarter. Invesco Ltd. grew its position in Endava by 5.0% in the 1st quarter. Invesco Ltd. now owns 3,440,658 shares of the company’s stock valued at $67,127,000 after buying an additional 164,475 shares during the last quarter. T. Rowe Price Investment Management Inc. grew its position in Endava by 7.2% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 2,549,317 shares of the company’s stock valued at $78,774,000 after buying an additional 171,048 shares during the last quarter. CDAM UK Ltd grew its position in Endava by 7.8% in the 4th quarter. CDAM UK Ltd now owns 2,348,674 shares of the company’s stock valued at $72,574,000 after buying an additional 169,147 shares during the last quarter. Finally, Alyeska Investment Group L.P. grew its position in Endava by 80.6% in the 4th quarter. Alyeska Investment Group L.P. now owns 1,806,044 shares of the company’s stock valued at $55,807,000 after buying an additional 805,903 shares during the last quarter. Institutional investors and hedge funds own 62.23% of the company’s stock.

Endava Trading Down 3.3%

Shares of DAVA opened at $13.55 on Monday. The company has a current ratio of 2.18, a quick ratio of 2.18 and a debt-to-equity ratio of 0.21. Endava has a 12-month low of $13.12 and a 12-month high of $34.94. The firm has a 50-day moving average price of $14.88 and a 200 day moving average price of $20.59. The firm has a market capitalization of $799.86 million, a P/E ratio of 35.66, a P/E/G ratio of 1.29 and a beta of 1.14.

About Endava

(Get Free Report

Endava plc provides technology services for clients in the consumer products, healthcare, mobility, and retail verticals in North America, Europe, the United Kingdom, and internationally. It offers ideation and production services in the payments and financial services, telecommunications, media, and technology verticals; and business analysis, data analytics, program management, digital product strategy, private equity value enhancement, IT strategy, architecture, extended reality, machine learning and artificial intelligence, product design, and user experience and visual design services.

Read More

Analyst Recommendations for Endava (NYSE:DAVA)

Receive News & Ratings for Endava Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Endava and related companies with MarketBeat.com's FREE daily email newsletter.